The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins.
amantadine
hemagglutinin
protein trafficking
viroporin
virus uncoating
Journal
Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724
Informations de publication
Date de publication:
31 08 2023
31 08 2023
Historique:
medline:
1
9
2023
pubmed:
4
8
2023
entrez:
4
8
2023
Statut:
ppublish
Résumé
The influenza A virus (IAV) M2 protein has proton channel activity, which plays a role in virus uncoating and may help to preserve the metastable conformation of the IAV hemagglutinin (HA). In contrast to the highly conserved M2 proteins of conventional IAV, the primary sequences of bat IAV H17N10 and H18N11 M2 proteins show remarkable divergence, suggesting that these proteins may differ in their biological function. We, therefore, assessed the proton channel activity of bat IAV M2 proteins and investigated its role in virus replication. Here, we show that the M2 proteins of bat IAV did not fully protect acid-sensitive HA of classical IAV from low pH-induced conformational change, indicating low proton channel activity. Interestingly, the N31S substitution not only rendered bat IAV M2 proteins sensitive to inhibition by amantadine but also preserved the metastable conformation of acid-sensitive HA to a greater extent. In contrast, the acid-stable HA of H18N11 did not rely on such support by M2 protein. When mutant M2(N31S) protein was expressed in the context of chimeric H18N11/H5N1(6:2) encoding HA and NA of avian IAV H5N1, amantadine significantly inhibited virus entry, suggesting that ion channel activity supported virus uncoating. Finally, the cytoplasmic domain of the H18N11 M2 protein mediated rapid internalization of the protein from the plasma membrane leading to low-level expression at the cell surface. However, cell surface levels of H18N11 M2 protein were significantly enhanced in cells infected with the chimeric H18N11/H5N1(6:2) virus. The potential role of the N1 sialidase in arresting M2 internalization is discussed. IMPORTANCE Bat IAV M2 proteins not only differ from the homologous proteins of classical IAV by their divergent primary sequence but are also unable to preserve the metastable conformation of acid-sensitive HA, indicating low proton channel activity. This unusual feature may help to avoid M2-mediated cytotoxic effects and inflammation in bats infected with H17N10 or H18N11. Unlike classical M2 proteins, bat IAV M2 proteins with the N31S substitution mediated increased protection of HA from acid-induced conformational change. This remarkable gain of function may help to understand how single point mutations can modulate proton channel activity. In addition, the cytoplasmic domain was found to be responsible for the low cell surface expression level of bat IAV M2 proteins. Given that the M2 cytoplasmic domain of conventional IAV is well known to participate in virus assembly at the plasma membrane, this atypical feature might have consequences for bat IAV budding and egress.
Identifiants
pubmed: 37540019
doi: 10.1128/jvi.00388-23
pmc: PMC10506471
doi:
Substances chimiques
Amantadine
BF4C9Z1J53
Hemagglutinin Glycoproteins, Influenza Virus
0
Protons
0
M2 protein, Influenza A virus
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0038823Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
J Biol Chem. 2002 Oct 18;277(42):39880-6
pubmed: 12183461
J Virol. 2006 Jun;80(11):5233-40
pubmed: 16699003
J Virol. 1996 Dec;70(12):8391-401
pubmed: 8970960
DNA Cell Biol. 2013 Oct;32(10):557-64
pubmed: 23945006
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):E6955-E6964
pubmed: 27791184
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1458-63
pubmed: 23297216
Nature. 2008 Jan 31;451(7178):591-5
pubmed: 18235503
PLoS One. 2011;6(10):e25858
pubmed: 21998709
Virology. 1992 Sep;190(1):11-8
pubmed: 1529523
Int J Mol Sci. 2017 Dec 07;18(12):
pubmed: 29215568
PLoS One. 2017 Mar 30;12(3):e0174827
pubmed: 28358853
Bioinformatics. 2008 Sep 15;24(18):2101-2
pubmed: 18662927
Cell Host Microbe. 2014 Feb 12;15(2):239-47
pubmed: 24528869
Virology. 1992 May;188(1):14-24
pubmed: 1566569
Proc Natl Acad Sci U S A. 2000 May 23;97(11):6108-13
pubmed: 10801978
J Virol. 1994 Feb;68(2):920-6
pubmed: 8289394
J Virol. 1995 Feb;69(2):1219-25
pubmed: 7529332
J Virol. 2009 Feb;83(4):1572-8
pubmed: 19052090
Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10282-7
pubmed: 10920189
J Gen Virol. 1991 Jun;72 ( Pt 6):1461-5
pubmed: 2045796
Subcell Biochem. 2018;88:329-377
pubmed: 29900504
Cell Rep. 2013 Mar 28;3(3):769-78
pubmed: 23434510
Cell. 1991 Oct 4;67(1):117-30
pubmed: 1913813
J Gen Virol. 2014 Aug;95(Pt 8):1634-1639
pubmed: 24814925
Int J Biochem Cell Biol. 2020 May;122:105738
pubmed: 32156572
J Cell Biol. 1996 May;133(4):733-47
pubmed: 8666660
Nat Microbiol. 2019 Dec;4(12):2298-2309
pubmed: 31527796
Mol Biol Cell. 1998 Sep;9(9):2477-90
pubmed: 9725907
J Cell Biol. 2003 Sep 1;162(5):773-9
pubmed: 12952931
Nat Rev Microbiol. 2012 Jul 02;10(8):563-74
pubmed: 22751485
Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11525-9
pubmed: 1763066
J Cell Biol. 1983 Oct;97(4):1243-8
pubmed: 6194163
Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11301-6
pubmed: 9326604
Antimicrob Agents Chemother. 2009 Oct;53(10):4457-63
pubmed: 19651904
J Virol. 2014 Nov;88(22):13029-46
pubmed: 25165113
J Virol. 1988 Aug;62(8):2762-72
pubmed: 2455818
Nature. 2019 Mar;567(7746):109-112
pubmed: 30787439
Virology. 1994 Aug 1;202(2):1007-11
pubmed: 7518161
Biophys J. 1996 Mar;70(3):1335-46
pubmed: 8785289
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Protein Sci. 2016 Aug;25(8):1551-4
pubmed: 27082171
Biotechnol J. 2009 Apr;4(4):544-53
pubmed: 19370716
J Virol. 2006 Aug;80(16):8178-89
pubmed: 16873274
Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1315-20
pubmed: 23302696
Virology. 1991 Jul;183(1):32-43
pubmed: 2053285
J Virol. 2002 Feb;76(3):1391-9
pubmed: 11773413
Am J Physiol Lung Cell Mol Physiol. 2013 May 1;304(9):L582-92
pubmed: 23457187
Nucleic Acids Res. 2015 Jul 1;43(W1):W408-12
pubmed: 25943549
Virology. 1982 Aug;121(1):157-67
pubmed: 18638751
J Gen Virol. 2015 Aug;96(8):2000-2027
pubmed: 26023149
Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15409-14
pubmed: 20713739
Traffic. 2010 Mar;11(3):348-60
pubmed: 20051050
J Biol Chem. 1999 Apr 2;274(14):9854-60
pubmed: 10092677
BMC Genomics. 2012 Oct 16;13:556
pubmed: 23067041
EMBO J. 1992 Jul;11(7):2407-14
pubmed: 1628614
Am J Physiol Lung Cell Mol Physiol. 2017 Nov 1;313(5):L845-L858
pubmed: 28775098
PLoS Pathog. 2013;9(10):e1003657
pubmed: 24130481
Nature. 1994 Sep 1;371(6492):37-43
pubmed: 8072525
J Virol. 2017 Apr 13;91(9):
pubmed: 28202765
Cell. 1992 May 1;69(3):517-28
pubmed: 1374685
Rev Med Virol. 2015 Nov;25(6):406-30
pubmed: 26467906
J Virol. 1994 Mar;68(3):1551-63
pubmed: 7508997
Vaccine. 2009 Feb 18;27(8):1174-83
pubmed: 19135116
Biochem J. 2015 Aug 15;470(1):131-44
pubmed: 26251452
Virology. 1992 Dec;191(2):541-9
pubmed: 1448912
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18635-6
pubmed: 23100536
Proc Natl Acad Sci U S A. 2016 Nov 8;113(45):12797-12802
pubmed: 27791106
Arch Virol. 2001 Dec;146(12):2275-89
pubmed: 11811679
FEBS Lett. 1995 Aug 28;371(1):9-12
pubmed: 7664891
Nat Commun. 2014 Jul 23;5:4448
pubmed: 25055345
PLoS One. 2016 Mar 30;11(3):e0152134
pubmed: 27028521
Protein Sci. 2012 Nov;21(11):1620-33
pubmed: 23001990
Biophys J. 2014 Apr 1;106(7):1447-56
pubmed: 24703306
J Infect Dis. 2007 Jul 15;196(2):249-57
pubmed: 17570112
Cell. 2010 Sep 17;142(6):902-13
pubmed: 20850012
J Virol. 2008 Oct;82(20):10059-70
pubmed: 18701586
J Virol. 2005 Mar;79(6):3595-605
pubmed: 15731254
Nature. 2008 Jan 31;451(7178):596-9
pubmed: 18235504
J Virol. 2020 Feb 14;94(5):
pubmed: 31801857
J Virol. 2001 Jun;75(12):5656-62
pubmed: 11356973
J Virol. 2015 Feb;89(4):1975-85
pubmed: 25473053
Methods Mol Biol. 2018;1836:1-21
pubmed: 30151566
FEBS Lett. 2003 Sep 18;552(1):28-34
pubmed: 12972148
Virology. 1992 Jan;186(1):324-30
pubmed: 1727609
J Am Chem Soc. 2019 Jul 24;141(29):11481-11488
pubmed: 31184871
PLoS One. 2013 Jun 10;8(6):e66059
pubmed: 23762463
PLoS Pathog. 2014 Oct 02;10(10):e1004420
pubmed: 25275541
Biophys J. 1995 Oct;69(4):1363-71
pubmed: 8534806
Nat Immunol. 2010 May;11(5):404-10
pubmed: 20383149
Viruses. 2022 Jan 05;14(1):
pubmed: 35062292
Nat Commun. 2021 Jul 20;12(1):4427
pubmed: 34285233
J Virol. 1994 Feb;68(2):911-9
pubmed: 7507186
Proc Natl Acad Sci U S A. 2012 Mar 13;109(11):4269-74
pubmed: 22371588
Adv Virus Res. 2020;106:1-38
pubmed: 32327145
Biomol NMR Assign. 2020 Apr;14(1):157-161
pubmed: 32157574